Industry Experts

Randall has worked for 20 years to make optimized protein constructs for diagnostic and pharmaceutical projects. He has a Ph.D. in Biochemistry from Duke University, where he specialized in protein folding and engineering, and has contributed to protein production and process development for 10 antibody therapeutics in oncology, immunology and pain indications. He is currently designing and directing biologics drug discovery projects at Quotient Therapeutics, leveraging their somatic genetics platform to deliver novel medicines to help patients in need.